Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 853-864 of 1464 results.
"We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital" Gamage et al (2025).
"Specifically, studies that decrease the treatment length or advocate for the early transition of intravenous to oral antibiotics in all neonates with suspected or culture-positive sepsis or pneumonia should be regarded with caution" Lawrence et al (2025).
"A recent scoping review discovered a significant deficit in the literature covering clinical aspects of vascular access device (VAD) selection, insertion, and, in particular, training and education. To answer some of these questions, we are conducting a quantitative survey throughout Europe to investigate healthcare professionals' current practices surrounding vascular access devices used for systemic anti-cancer therapy" Duggan et al (2025).
"EJV access offers reduced operative time without increasing complication risk compared to IJV access for TIVAP placement in children. It may be preferred when minimizing anesthesia exposure is important" Hamzah et al (2025).
"Phlebitis incidence remains above recommended levels. Multivariable analysis identified female sex, a higher number of infused medications, older patient age, larger hospital size, and longer PIVC dwell time as the main independent predictors of phlebitis" Cernuda-Martínez et al (2025).
"These data suggest that the tibial and humeral IO routes of first epinephrine administration were associated with marginally prolonged resuscitation duration after drug administration and decreasing hazard of ROSC" Hubble et al (2025).
"This study showed that ipsilateral or contralateral placement did not affect the distance between CVC and CVDC line tips. There were no significant adverse changes in cardiovascular parameters or noradrenaline dose when CRRT was commenced regardless of whether the lines were inserted ipsilaterally or contralaterally" Hobson et al (2025).
"Tissue adhesives optimise VAD dressing by enhancing haemostasis, securement and infection control. This practice improves patient outcomes and reduces costs" Hitchcock and Almerol (2025).
"The rate of skin injury and complications are observed to be as high as 16% for exit site infection and 11% for dermatitis. Infection is an important outcome, but not the sole outcome to consider during CVAD site observation" Pitt et al (2025).
"These findings emphasize the importance of continuous monitoring, individualized infection prevention strategies in oncology nursing practice. Future research with larger datasets is needed to validate these findings and develop tailored interventions to reduce CLABSI risks" Belloni et al (2025).
"The implementation of a NICU-specific CLABSI prevention bundle significantly reduced infection rates and lowered healthcare costs by approximately 80% per patient" Iyigun et al (2025).
"Ultrasound (US) guided central inserted central catheter (CICC) of the brachiocephalic vein (BCV) is a new approach that may be advantageous in case of difficult central venous access" Mghirbi et al (2025).
